<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JOP</journal-id>
<journal-id journal-id-type="hwp">spjop</journal-id>
<journal-id journal-id-type="nlm-ta">J Psychopharmacol</journal-id>
<journal-title>Journal of Psychopharmacology</journal-title>
<issn pub-type="ppub">0269-8811</issn>
<issn pub-type="epub">1461-7285</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0269881111431749</article-id>
<article-id pub-id-type="publisher-id">10.1177_0269881111431749</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Papers</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of exposure to stress and modulation by mecamylamine</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Bhutada</surname><given-names>Pravinkumar</given-names></name>
<xref ref-type="aff" rid="aff1-0269881111431749">1</xref>
<xref ref-type="aff" rid="aff2-0269881111431749">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Mundhada</surname><given-names>Yogita</given-names></name>
<xref ref-type="aff" rid="aff3-0269881111431749">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ghodki</surname><given-names>Yogesh</given-names></name>
<xref ref-type="aff" rid="aff2-0269881111431749">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Dixit</surname><given-names>Pankaj</given-names></name>
<xref ref-type="aff" rid="aff4-0269881111431749">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Umathe</surname><given-names>Sudhir</given-names></name>
<xref ref-type="aff" rid="aff3-0269881111431749">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Jain</surname><given-names>Kishor</given-names></name>
<xref ref-type="aff" rid="aff1-0269881111431749">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0269881111431749"><label>1</label>Sinhgad College of Pharmacy, Post-Graduate Research Department, Vadgaon (Bk), Pune, Maharashtra, India</aff>
<aff id="aff2-0269881111431749"><label>2</label>Agnihotri College of Pharmacy, Pharmacology Division, Bapuji Wadi, Sindhi (Meghe), Wardha, Maharashtra, India</aff>
<aff id="aff3-0269881111431749"><label>3</label>Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, Maharashtra, India</aff>
<aff id="aff4-0269881111431749"><label>4</label>College of Pharmacy, IPS Academy, Hukmakhedi, Knowledge Village, Rajendranagar, Indore, Madhya Pradesh, India</aff>
<author-notes>
<corresp id="corresp1-0269881111431749">Pravinkumar S Bhutada, Sinhgad College of Pharmacy, Post-Graduate Research Department, Off Sinhgad Road, Vadgaon (Bk), Pune 41, Maharashtra, India Email: <email>psbhutada@live.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>2</month>
<year>2012</year>
</pub-date>
<volume>26</volume>
<issue>2</issue>
<fpage>315</fpage>
<lpage>323</lpage>
<permissions>
<copyright-statement>© British Association for Psychopharmacology 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">British Association for Psychopharmacology</copyright-holder>
</permissions>
<abstract>
<p>Nicotinic acetylcholine receptors mediate some of the rewarding and motivational effects of ethanol, including relapses. Relapses are common in drug addicts during abstinence when exposure to any stressor ensues. However, the role of nicotinic acetylcholine receptors in the ethanol- and stress-induced reinstatement of ethanol-induced conditioned place preference has not yet been explored. Therefore, the present study investigated the influence of mecamylamine, a nicotinic acetylcholine receptors antagonist on acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in adult male Swiss mice. The results revealed that mecamylamine (0.1–10 µg/mouse, intracerebroventricularly) dose dependently prevented the development, expression, and reinstatement of ethanol-induced conditioned place preference. Further, acute treatment with mecamylamine blocked the restraint stress and forced swim stress-induced reinstatement of ethanol-induced conditioned place preference. All of these treatments had no influence on the locomotor activity. Therefore, it is concluded that mecamylamine blocks the acquisition, expression and reinstatement of conditioned reinforcing effects of ethanol without <italic>per se</italic> reinforcing or aversive influence. This ability of mecamylamine might be a potential advantage in the treatment of alcoholism.</p>
</abstract>
<kwd-group>
<kwd>Alcoholism</kwd>
<kwd>drug-induced reinstatement</kwd>
<kwd>ethanol preference</kwd>
<kwd>ethanol relapse</kwd>
<kwd>forced swim stress</kwd>
<kwd>motivational effects</kwd>
<kwd>nicotinic acetylcholine receptors system</kwd>
<kwd>conditioned place preference</kwd>
<kwd>restraint stress</kwd>
<kwd>rewarding effects</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0269881111431749" sec-type="intro">
<title>Introduction</title>
<p>Drug addiction is a chronic relapsing brain disorder characterized by neurobiological changes leading to compulsive drug-seeking and drug-taking behavior. One of the main problems in the treatment of addiction is the high rate of relapse to drug use even after a long period of abstinence (<xref ref-type="bibr" rid="bibr21-0269881111431749">Fiore, 2000</xref>; <xref ref-type="bibr" rid="bibr56-0269881111431749">Shalev et al., 2002</xref>). Such behavior ensues after permanent alterations in the brain architecture (<xref ref-type="bibr" rid="bibr47-0269881111431749">Nestler, 2004</xref>).</p>
<p>Exposure to stress is a key factor in vulnerability to drug abuse. It is thought that stress exposure and alcohol intake are closely related, and are central to the etiology of alcoholism (<xref ref-type="bibr" rid="bibr51-0269881111431749">Pohorecky, 1981</xref>). Numerous clinical studies report that exposure to stress can induce relapse to drug seeking (<xref ref-type="bibr" rid="bibr32-0269881111431749">Lamon and Alonzo, 1997</xref>; <xref ref-type="bibr" rid="bibr13-0269881111431749">Brady and Sonne, 1999</xref>; <xref ref-type="bibr" rid="bibr60-0269881111431749">Sinha et al., 1999</xref>; <xref ref-type="bibr" rid="bibr59-0269881111431749">Sinha, 2001</xref>). It is also reported that exposure to inescapable stressor (forced swim stress) potentiate ethanol-induced rewarding effects (<xref ref-type="bibr" rid="bibr62-0269881111431749">Sperling et al., 2010</xref>).</p>
<p>The role of nicotinic acetylcholine receptors in alcoholism is established in several electrophysiological, behavioral, and genetic studies (<xref ref-type="bibr" rid="bibr33-0269881111431749">Larsson and Engel, 2004</xref>; <xref ref-type="bibr" rid="bibr24-0269881111431749">Ford et al., 2009</xref>; <xref ref-type="bibr" rid="bibr6-0269881111431749">Bhutada et al., 2010c</xref>, <xref ref-type="bibr" rid="bibr7-0269881111431749">2010d</xref>; <xref ref-type="bibr" rid="bibr28-0269881111431749">Kamens et al., 2010</xref>). The role of nicotinic acetylcholine receptors in ventral tegmental area and nucleus accumbens is well established in ethanol intake and preference, as well as ethanol-induced stimulation of the mesolimbic dopaminergic system (<xref ref-type="bibr" rid="bibr46-0269881111431749">Nadal et al., 1998</xref>; <xref ref-type="bibr" rid="bibr36-0269881111431749">Le et al., 2000</xref>; <xref ref-type="bibr" rid="bibr61-0269881111431749">Soderpalm et al., 2000</xref>; <xref ref-type="bibr" rid="bibr12-0269881111431749">Blomqvist et al., 2002</xref>; <xref ref-type="bibr" rid="bibr17-0269881111431749">Chi and de Wit, 2003</xref>; <xref ref-type="bibr" rid="bibr33-0269881111431749">Larsson and Engel, 2004</xref>; <xref ref-type="bibr" rid="bibr66-0269881111431749">Young et al., 2005</xref>). Recent studies have also documented that nicotinic acetylcholine receptor antagonists block the relapse, namely ethanol drinking behavior (<xref ref-type="bibr" rid="bibr30-0269881111431749">Kuzmin et al., 2009</xref>) and cue-induced relapse-like response in rats (<xref ref-type="bibr" rid="bibr39-0269881111431749">Lof et al., 2007</xref>).</p>
<p>Relapse to drug consumption is the most difficult challenge in the treatment of addiction, and the neurobiological mechanisms that underlie the persistence of such behavior remain poorly understood. Evidence suggests a role of nicotinic acetylcholine receptors in the stress-induced reinstatement of ethanol intake. Therefore, we hypothesized that nicotinic acetylcholine receptor signaling may mediate the stress-induced reinstatement of ethanol-induced conditioned place preference (CPP). This hypothesis was tested in an animal model of reinstatement of ethanol-induced CPP in mice, as it is suggested to be useful for study of relapse behavior (<xref ref-type="bibr" rid="bibr45-0269881111431749">Mueller and Stewart, 2000</xref>; <xref ref-type="bibr" rid="bibr27-0269881111431749">Itzhak and Martin, 2002</xref>; <xref ref-type="bibr" rid="bibr40-0269881111431749">Lu et al., 2005</xref>; <xref ref-type="bibr" rid="bibr8-0269881111431749">Biala and Budzynska, 2006</xref>).</p>
<p>We have used mecamylamine in the present investigation to study the role of nicotinic acetylcholine receptors in ethanol-induced CPP and its modulation by stress as mecamylamine is a negative allosteric modulator and non-competitive antagonist of nicotinic acetylcholine receptor, having high affinity for the α4β2 subtype. In addition, mecamylamine is reported to reduce the subjective euphoria of ethanol in humans (<xref ref-type="bibr" rid="bibr11-0269881111431749">Blomqvist et al., 1996</xref>; <xref ref-type="bibr" rid="bibr17-0269881111431749">Chi and de Wit, 2003</xref>; <xref ref-type="bibr" rid="bibr36-0269881111431749">Le et al., 2000</xref>) and has recently been approved for the treatment of nicotine addiction.</p>
</sec>
<sec id="section2-0269881111431749" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="section3-0269881111431749">
<title>Animals</title>
<p>Adult male Swiss albino mice (24–30 g), born and reared in the Animal House of the Agnihotri College of Pharmacy, Wardha, from a stock originally purchased from Shree Farm, Bhandara, India, were used in the present investigations. Mice were group housed (four per cage) in opaque polypropylene cages (28 cm × 21 cm × 14 cm) and maintained at 23 ± 2°C under 12:12 h light/dark cycle (light cycle: 08:00–20:00), with free access to standard rodent diet and tap water. Animals were naive to drug treatments and experimentation at the beginning of all of the experiments. Each experimental group comprised six to eight mice. Behavioral studies were carried out between 09:00 and 14:00 to minimize circadian influences (if any). Testing was carried out in a counterbalanced order with respect to the treatment conditions, in a noise-free room. All of the experiments were approved by the Institutional Animal Ethics Committee (IAEC), constituted for the purpose of control and supervision of experimental animals by Ministry of Environment and Forests, Government of India, New Delhi, India.</p>
</sec>
<sec id="section4-0269881111431749">
<title>Drugs and solutions</title>
<p>Mecamylamine hydrochloride (Sigma-Aldrich Co, St. Louis, MO) and ethanol (Changshu Yangyuan Chemical, China) were dissolved in 0.9% saline. Mecamylamine was administered at a dose of 0.1–10 µg/mouse, intracerebroventricularly (i.c.v.), in a volume of 1 µl, on the basis of our preliminary studies and previous report (<xref ref-type="bibr" rid="bibr68-0269881111431749">Zarrindast et al., 2001</xref>). Mecamylamine was administered by intracerebroventricular route to avoid the involvement of peripheral nicotinic acetylcholine receptor (if any) in the effects. The ethanol was administered at dose of 2 g/kg intraperitoneally (i.p.) in a volume of 12.5 ml/kg body weight, as this dose was previously demonstrated to induce CPP in mice (<xref ref-type="bibr" rid="bibr54-0269881111431749">Risinger and Oakes, 1996</xref>; <xref ref-type="bibr" rid="bibr41-0269881111431749">Maurice et al., 2003</xref>; <xref ref-type="bibr" rid="bibr22-0269881111431749">Font et al., 2006</xref>, <xref ref-type="bibr" rid="bibr23-0269881111431749">2008</xref>; <xref ref-type="bibr" rid="bibr4-0269881111431749">Bhutada et al., 2010a</xref>).</p>
</sec>
<sec id="section5-0269881111431749">
<title>Intracerebroventricular injection</title>
<p>The intracerebroventricular cannulation was carried out as described previously (<xref ref-type="bibr" rid="bibr5-0269881111431749">Bhutada et al., 2010b</xref>). In brief, mice were anesthetized with ketamine–xylazine combination (100 mg/kg and 5 mg/kg respectively, intramuscularly [i.m.]) and stainless steel cannulae (Becton Dickinson, India, 24 gauge) were stereotaxically implanted with coordinates from Paxinos and Franklin (AP –0.82 mm; ML +1.5 mm and DV +2.0 mm; related to bregma). Guide cannulae were secured to the skull using mounting screws and dental cement (Dental Products of India, Mumbai). A stainless steel dummy cannula was used to occlude the guide cannula when not in use. The animals were then allowed to recover for a week under an antimicrobial cover of cefotaxim (50 mg/kg/day, subcutaneously [s.c.]), during which they were habituated to the experimental conditions such as the transfer of the animal from the husbandry to the testing room, and removal and occlusion of guide cannula by dummy cannula to minimize non-specific stress (if any). Injections were made using a 5 μL Hamilton syringe (Hamilton, NV, USA) connected to an internal cannula (31 gauge) by polyethylene tubing with a volume of 1.0 μL was administered over a period of 60 s into the right lateral ventricle. The injection cannula was left in place for a further 60 s before being slowly withdrawn to avoid back flow. At the end of all i.c.v. experiments, a dilute India ink was injected (1.0 μL, i.c.v.) and animals were euthanized by pentobarbitone overdose. Only data from animals that showed a uniform distribution of ink into the lateral ventricles were used for statistical analyses. Less than 10% of the mice were eliminated from results because of inaccurate cannula placement or injection leakage.</p>
</sec>
<sec id="section6-0269881111431749">
<title>Conditioned place preference</title>
<p>The CPP test was carried out using Swiss mice as described earlier (<xref ref-type="bibr" rid="bibr23-0269881111431749">Font et al., 2008</xref>; <xref ref-type="bibr" rid="bibr4-0269881111431749">Bhutada et al., 2010a</xref>). The CPP experiments were conducted in a three-chambered place conditioning apparatus connected to a digital recorder and housed in a light- and sound-attenuated chamber (VJ Instruments, Buldhana, India). Two (6.6” × 5”) conditioning chambers, one white with a rough floor and the other black with a smooth floor, were connected by a small (2.85” × 5”) central access chamber with gray walls and a smooth polyvinyl chloride floor. In addition, each chamber was equipped with a house light, with the luminance (40 lux) adjusted such that the environmental (visual and tactile) cues should not produce a significant baseline preference for a specific chamber. All chambers were separated by manually operated guillotine doors. The individual chamber activity was determined by photobeam breaks recorded by a digital recorder. The experiment was carried in different phases detailed below.</p>
<p>The experiment was performed according to a Pavlovian procedure and consisted of 5 phases conducted for 20 consecutive days using an unbiased procedure: (i) adaptation (day 1), (ii) conditioning with ethanol (days 2, 4, 6, and 8), and conditioning with vehicle (days 3, 5, 7, and 9), (iii) post-conditioning test on day 10; (iv) extinction phase (days 11 to 19), and (v) reinstatement phase on day 20 (<xref ref-type="table" rid="table1-0269881111431749">Table 1</xref>).</p>
<table-wrap id="table1-0269881111431749" position="float">
<label>Table 1.</label>
<caption>
<p>Representation of different phases of conditioned place preference test</p>
</caption>
<graphic alternate-form-of="table1-0269881111431749" xlink:href="10.1177_0269881111431749-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Study/phases</th>
<th align="left">Habituation</th>
<th align="left" colspan="2">Conditioning</th>
<th align="left">CPP</th>
<th align="left" colspan="2">Extinction</th>
<th align="left">Reinstatement</th>
</tr>
<tr>
<th/>
<th align="left">Day 1</th>
<th align="left">Day 2, 4, 6 and 8</th>
<th align="left">Day 3, 5, 7 and 9</th>
<th align="left">Day 10</th>
<th align="left">Day 11 to 18 (conditioning)</th>
<th align="left">Day 19 (CPP)</th>
<th align="left">Day 20 (CPP)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Acquisition</td>
<td>Saline</td>
<td>Mecamylamine + ethanol</td>
<td>Saline + saline</td>
<td>Saline</td>
<td>NA</td>
<td>NA</td>
<td>NA</td>
</tr>
<tr>
<td>Expression</td>
<td>Saline</td>
<td>Saline + ethanol</td>
<td>Saline + saline</td>
<td>Mecamylamine + Saline</td>
<td>NA</td>
<td>NA</td>
<td>NA</td>
</tr>
<tr>
<td>Reinstatement</td>
<td>Saline</td>
<td>Saline + ethanol</td>
<td>Saline + saline</td>
<td>Saline + saline</td>
<td>Saline + saline</td>
<td>Saline + Saline</td>
<td>Mecamylamine + ethanol/Stress</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0269881111431749">
<p>CPP, conditioned place preference test; NA, not applicable</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>During the adaptation, mice were carried into the testing room, weighed and handled by the experimenter. This adaptation phase was intended to reduce the novelty and stress associated with handling and injections. During conditionings, mice received ethanol (2g/kg, i.p.) or vehicle (12.5 mL/kg, i.p.) 10 min before being placed into the respective arm (either black or white) of the apparatus for 5 min. The neutral zone was never used during conditioning and was blocked by guillotine doors. The ethanol dose and conditioning phase duration were selected on the basis of previous studies and the fact that they are known to induce place preference in Swiss mice (<xref ref-type="bibr" rid="bibr54-0269881111431749">Risinger and Oakes, 1996</xref>; <xref ref-type="bibr" rid="bibr22-0269881111431749">Font et al., 2006</xref>, <xref ref-type="bibr" rid="bibr23-0269881111431749">2008</xref>; <xref ref-type="bibr" rid="bibr4-0269881111431749">Bhutada et al., 2010a</xref>). In the post-test period, an individual mouse was placed in the central chamber and had free access to all of the chambers for the duration of 5 min (test session), and total time spent in each chamber was recorded. The extinction procedure was carried out as per the method described earlier (<xref ref-type="bibr" rid="bibr23-0269881111431749">Font et al., 2008</xref>; <xref ref-type="bibr" rid="bibr57-0269881111431749">Shoblock et al., 2011</xref>) with slight modifications based on our preliminary studies. The extinction phase was similar to the conditioning phase in that it was carried out over 8 days, with 5-min conditioning sessions each day. During this phase, each mouse was administered with saline and confined to the drug-paired compartment for 5 min. On alternate days, animals were injected with saline and confined to the other compartment for 5 min. After the last day of the extinction phase, all animals were exposed to a new test session (extinction) on day 19. The reinstatement was performed 24 h after extinction test in the mice, which showed extinction (day 20). The animals were administered with various treatments or ethanol (1.0 g/kg, i.p.). This sub-conditioning dose of ethanol (1.0 g/kg, i.p.) is reported to reinstate the extinguished ethanol-induced CPP in mice (<xref ref-type="bibr" rid="bibr57-0269881111431749">Shoblock et al., 2011</xref>). Ten minutes thereafter animals were subjected to CPP test (reinstatement) and time spent in each chamber was recorded. Time spent in the ethanol paired chamber was used for statistical comparisons.</p>
</sec>
<sec id="section7-0269881111431749">
<title>Induction of stress</title>
<p>Mice were subjected to restraint stress by an earlier reported method (<xref ref-type="bibr" rid="bibr63-0269881111431749">Umathe et al., 2008</xref>). In brief, a mouse was placed in a 50 mL cylindrical polypropylene tube and the open ends were covered with a wire net for adequate ventilation.</p>
<p>Mice were subjected to forced swim stress by a method described earlier (<xref ref-type="bibr" rid="bibr5-0269881111431749">Bhutada et al., 2010b</xref>). Mice were placed in a glass cylinder (height: 35 cm; diameter: 17 cm) filled with water (25 ± 1°C) to a depth of 25 cm. The water depth was adjusted so that the animals must swim or float without their hind limbs or tail touching to the bottom.</p>
</sec>
<sec id="section8-0269881111431749">
<title>Experiment 1: effect of mecamylamine on the acquisition of ethanol-induced CPP</title>
<p>To determine the effects of mecamylamine on the acquisition of ethanol-induced CPP, mecamylamine (0.1–10 µg/mouse, i.c.v.) or vehicle (saline) was injected in a volume of 1 µL, 10 min before each ethanol (2 g/kg, i.p.) conditioning on days 2, 4, 6, and 8. On day 10, animals were injected with saline and placed into the apparatus for 5 min, with free access to all chambers, and the time spent in each chamber was recorded as a test for conditioned place preference. In a separate study, to determine whether the effects of mecamylamine on ethanol-induced CPP were due to intrinsic aversive properties, mice were conditioned to mecamylamine or its vehicle, without ethanol, using the same procedure as above.</p>
</sec>
<sec id="section9-0269881111431749">
<title>Experiment 2: effect of mecamylamine on the expression of ethanol-induced CPP</title>
<p>Separate groups of mice were conditioned to 2 g/kg ethanol as described above. On the test day (day 10), mice were pretreated with mecamylamine (0.1–10 µg/mouse, i.c.v.) or vehicle (saline) 10 min before saline injection. Ten min after saline injection, mice were subjected to CPP test.</p>
</sec>
<sec id="section10-0269881111431749">
<title>Experiment 3: effect of mecamylamine on the reinstatement of ethanol-induced CPP</title>
<p>A separate group of mice were conditioned to 2 g/kg ethanol or saline as described above and given a 5 min CPP test on day 10. From day 11 to day 18, mice were administered with saline and confined to any one chamber on alternate days. On day 19, a CPP test was again carried out to test whether ethanol-induced CPP was extinguished. On day 20, mice were treated with mecamylamine (0.1 µg/mouse, i.c.v.) or vehicle, 10 min before receiving a priming injection of ethanol (1 g/kg, i.p.) or vehicle (saline). Ten minutes after ethanol injection mice were placed in the apparatus for another 5 min test of CPP (reinstatement).</p>
</sec>
<sec id="section11-0269881111431749">
<title>Experiment 4: influence of mecamylamine on the stress-induced reinstatement of ethanol-induced CPP</title>
<p>A separate group of animals were conditioned to 2 g/kg ethanol or saline as described above and given a 5 min CPP test on day 10. From day 11 to day 18, mice were administered with saline and confined to any one chamber on alternate days. On day 19, a CPP test (extinction) was again carried out to test whether ethanol-induced CPP was extinguished. On day 20, mice were treated with mecamylamine (0.1 µg/mouse, i.c.v.) or vehicle, 10 min before subjecting to either forced swim stress or restraint stress (15 min). Ten minutes after stress, mice were placed in the apparatus for another 5 min test of CPP (reinstatement).</p>
</sec>
<sec id="section12-0269881111431749">
<title>Data analysis</title>
<p>The results are expressed as a mean ± standard error of the mean (SEM). Data were analyzed using one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparison tests as described earlier (<xref ref-type="bibr" rid="bibr31-0269881111431749">Kuzmin et al., 2003</xref>; <xref ref-type="bibr" rid="bibr9-0269881111431749">Biala and Budzynska, 2008</xref>). <italic>p</italic> &lt; 0.05 was considered statistically significant in all cases.</p>
</sec>
</sec>
<sec id="section13-0269881111431749" sec-type="results">
<title>Results</title>
<sec id="section14-0269881111431749">
<title>Effect of mecamylamine on the acquisition of ethanol-induced CPP</title>
<p>The average time spent in ethanol paired black and white chambers during test was indifferent (black: 165.25 ± 11.03 seconds; and white: 162.75 ± 10.52 seconds). One-way ANOVA revealed that mice administered with mecamylamine (0.1, 1.0, and 10 µg/mouse, i.c.v.), 10 min prior to each ethanol (2.0 g/kg, i.p.) injection on days 2, 4, 6, and 8 (during development of ethanol-induced CPP), spent a significantly shorter time in the ethanol paired chamber during the CPP test on day 10 [<italic>F</italic>(7,56) = 9.611, <italic>p</italic> &lt; 0.0001] when compared with the vehicle-treated group (<xref ref-type="fig" rid="fig1-0269881111431749">Figure 1</xref>). Post hoc test further revealed that mecamylamine (1 or 10 µg/mouse, i.c.v.) significantly and dose dependently reduced the development of ethanol-induced CPP response (<italic>p</italic> &lt; 0.01 and <italic>p</italic> &lt; 0.001, respectively). Lower dose of mecamylamine (0.1 µg/mouse, i.c.v.) also had some inhibitory influence, but failed to attain statistical significant level. Further, repeated administration of mecamylamine had no influence on the number of crossings between the compartments [<italic>F</italic>(7,56) = 1.049, <italic>p</italic> = 0.4082] (<xref ref-type="fig" rid="fig1-0269881111431749">Figure 1</xref>). Post hoc test further revealed that repeated administration of mecamylamine did not show any preference to any chamber when administered in the saline-conditioned group.</p>
<fig id="fig1-0269881111431749" position="float">
<label>Figure 1.</label>
<caption>
<p>Effect of mecamylamine on the acquisition of ethanol-induced conditioned place preference. Each value represents the mean ± SEM (<italic>n</italic> = 7 or 8). *<italic>p</italic> &lt; 0.001 versus [(vehicle + saline in conditioning) + (vehicle + saline in testing)]; <sup>#</sup><italic>p</italic> &lt; 0.01, <sup>@</sup><italic>p</italic> &lt; 0.001 versus [(vehicle + ethanol in conditioning) + (vehicle + saline in testing)] treated group (one-way ANOVA followed by Tukey’s multiple comparison test).</p>
</caption>
<graphic xlink:href="10.1177_0269881111431749-fig1.tif"/>
</fig>
</sec>
<sec id="section15-0269881111431749">
<title>Effect of mecamylamine on the expression of ethanol-induced CPP</title>
<p>One-way ANOVA indicated that acute mecamylamine treatment significantly decreased the expression of ethanol-induced CPP [<italic>F</italic>(7,56) = 10.39, <italic>p</italic> &lt; 0.0001] (<xref ref-type="fig" rid="fig2-0269881111431749">Figure 2</xref>). On day 10 (test day), mice treated with vehicle plus saline (12.5 ml/kg, i.p.) in ethanol (2.0 g/kg, i.p.) conditioned group, spent a significantly longer time in the ethanol paired chamber (<italic>p</italic> &lt; 0.001) when compared with vehicle treatment in the saline-conditioned mice, indicated the development of CPP to the effect of ethanol (2.0 g/kg, i.p.), whereas mecamylamine (0.1, 1.0, and 10 µg/mouse, i.c.v.) treatment on day 10 prior to saline, exhibited significantly reduced time spent in the ethanol-conditioned chamber as compared with vehicle treatment (<italic>p</italic> &lt; 0.01, <italic>p</italic> &lt; 0.001, <italic>p</italic> &lt; 0.001, respectively). Moreover, mecamylamine treatment had no significant influence on the number of crossings between the compartments [<italic>F</italic>(7,56) = 0.7919, <italic>p</italic> = 0.5972] (<xref ref-type="fig" rid="fig2-0269881111431749">Figure 2</xref>).</p>
<fig id="fig2-0269881111431749" position="float">
<label>Figure 2.</label>
<caption>
<p>Effect of mecamylamine on the expression of ethanol-induced conditioned place preference. Each value represents the mean ± SEM (<italic>n</italic> = 7 or 8). *<italic>p</italic> &lt; 0.001 versus [(vehicle + saline in conditioning) + (vehicle + saline in testing)]; <sup>#</sup><italic>p</italic> &lt; 0.01, <sup>@</sup><italic>p</italic> &lt; 0.001 versus [(vehicle + ethanol in conditioning) + (vehicle + saline in testing)] treated group (one-way ANOVA followed by Tukey’s multiple comparison test).</p>
</caption>
<graphic xlink:href="10.1177_0269881111431749-fig2.tif"/>
</fig>
</sec>
<sec id="section16-0269881111431749">
<title>Effect of mecamylamine on the reinstatement of ethanol-induced CPP</title>
<p>The priming injection of ethanol (1.0 g/kg, i.p.) injected 1 day after the extinction trial (day 20), completely reinstated the extinguished ethanol-induced CPP, whereas pretreatment with nicotinic acetylcholine receptors antagonist, mecamylamine, significantly inhibited the priming effect of ethanol in ethanol-conditioned mice [<italic>F</italic>(10,64) = 15.03, <italic>p</italic> &lt; 0.0001] (<xref ref-type="fig" rid="fig3-0269881111431749">Figure 3</xref>). Post-hoc individual comparisons test indicated a significant (<italic>p</italic> &lt; 0.01) effect of mecamylamine (0.1 µg/mouse, i.c.v.) on ethanol reinstated ethanol-induced CPP. Moreover, these changes in CPP were unrelated to changes in locomotor activity as indicated by no change in number of crossings between the compartments (<xref ref-type="fig" rid="fig3-0269881111431749">Figure 3</xref>). Post hoc test revealed that acute treatment with mecamylamine did not shown any preference to any chamber when administered in the saline-conditioned group. Further, administration of ethanol (1.0 g/kg) on reinstatement day in saline-conditioned animals had no significant influence when compared with saline (<italic>p</italic> &gt; 0.05).</p>
<fig id="fig3-0269881111431749" position="float">
<label>Figure 3.</label>
<caption>
<p>Effects of mecamylamine (0.1 µg/mouse, i.c.v.) on the reinstatement of ethanol (2.0 g/kg, i.p.) conditioned place preference caused by a priming dose of ethanol (1.0 g/kg, i.p.). Place preference procedure performed thrice after conditioning, i.e. test, extinction trial and reinstatement. Data represent mean ± SEM (<italic>n</italic> = 6 or 7) and are expressed as the time spent in ethanol paired chamber. *<italic>p</italic> &lt; 0.001 versus saline-conditioned control group receiving either saline or ethanol (1.0 g/kg) injection on the reinstatement day; <sup>&amp;</sup><italic>p</italic> &lt; 0.01 versus ethanol-conditioned group given ethanol injection on the reinstatement day (one-way ANOVA followed by Tukey’s multiple comparison test).</p>
</caption>
<graphic xlink:href="10.1177_0269881111431749-fig3.tif"/>
</fig>
</sec>
<sec id="section17-0269881111431749">
<title>Influence of mecamylamine on the stress-induced reinstatement of ethanol-induced CPP</title>
<p>Mice subjected to a single session of either forced swim stress or restraint stress (15 min), 1 day after the extinction trial (day 20), completely reinstated the extinguished ethanol-induced CPP (<xref ref-type="fig" rid="fig4-0269881111431749">Figures 4</xref> and <xref ref-type="fig" rid="fig5-0269881111431749">5</xref>, respectively), whereas pretreatment with nicotinic acetylcholine receptors antagonist, mecamylamine, significantly inhibited the priming effect of stressors in ethanol-treated mice [forced swim stress: <italic>F</italic>(9,57) = 38.56, <italic>p</italic> &lt; 0.0001; restraint stress: <italic>F</italic>(9,59) = 18.19, <italic>p</italic> &lt; 0.0001]. Post hoc individual comparisons test indicated a significant effect of mecamylamine at a dose of (0.1 µg/mouse, i.c.v.) (<italic>p</italic> &lt; 0.001) on stress reinstated ethanol-induced CPP. Moreover, these changes in CPP after stress and mecamylamine treatment in the stressed group were unrelated to changes in locomotor activity as indicated by no change in number of crossings between the compartments (<xref ref-type="fig" rid="fig4-0269881111431749">Figures 4</xref> and <xref ref-type="fig" rid="fig5-0269881111431749">5</xref>). Further, animals subjected to stress on reinstatement day in saline-conditioned animals had no significant influence when compared with saline (<italic>p</italic> &gt; 0.05).</p>
<fig id="fig4-0269881111431749" position="float">
<label>Figure 4.</label>
<caption>
<p>Effects of mecamylamine (0.1 µg/mouse, i.c.v.) on the reinstatement of ethanol (2.0 g/kg, i.p.) conditioned place preference caused by priming of single session of forced swim stress. Place preference procedure performed thrice after conditioning, i.e. test, extinction trial and reinstatement. Data represent mean ± SEM (<italic>n</italic> = 6 or 7) and are expressed as the time spent in the ethanol paired chamber. *<italic>p</italic> &lt; 0.001 versus saline-conditioned control group receiving either saline injection or subjected to forced swim stress on the reinstatement day; <sup>&amp;</sup><italic>p</italic> &lt; 0.001 versus ethanol-conditioned group exposed to forced swim stress on the reinstatement day (one-way ANOVA followed by Tukey’s multiple comparison test).</p>
</caption>
<graphic xlink:href="10.1177_0269881111431749-fig4.tif"/>
</fig>
<fig id="fig5-0269881111431749" position="float">
<label>Figure 5.</label>
<caption>
<p>Effects of mecamylamine (0.1 µg/mouse, i.c.v.) on the reinstatement of ethanol (2.0 g/kg, i.p.) conditioned place preference caused by priming of single session of restraint stress. Place preference procedure performed thrice after conditioning, i.e. test, extinction trial and reinstatement. Data represent mean ± SEM (<italic>n</italic> = 6 or 7) and are expressed as the time spent in the ethanol paired chamber. *<italic>p</italic> &lt; 0.001 versus saline-conditioned control group receiving either saline injection or subjected to restraint stress on the reinstatement day; <sup>&amp;</sup><italic>p</italic> &lt; 0.001 versus ethanol-conditioned group exposed to restraint stress on the reinstatement day (one-way ANOVA followed by Tukey’s multiple comparison test).</p>
</caption>
<graphic xlink:href="10.1177_0269881111431749-fig5.tif"/>
</fig>
</sec>
</sec>
<sec id="section18-0269881111431749" sec-type="discussion">
<title>Discussion</title>
<p>The main aim of the present study was to determine the role of nicotinic acetylcholine receptors in the stress-induced reinstatement of ethanol-induced CPP along with the acquisition, expression and reinstatement of ethanol-induced CPP. Our results demonstrate that mecamylamine blocks the forced swim and restraint stress-induced reinstatement of ethanol-induced CPP. Further, it also blocked the development and expression of ethanol-induced CPP in mice. Earlier reports have shown that mecamylamine blocks the ethanol-plus nicotine-induced CPP (<xref ref-type="bibr" rid="bibr69-0269881111431749">Zarrindast et al., 2010</xref>) and morphine- or nicotine-induced reinstatement of nicotine-induced CPP (<xref ref-type="bibr" rid="bibr52-0269881111431749">Rezayof et al., 2007</xref>; <xref ref-type="bibr" rid="bibr50-0269881111431749">Pascual et al., 2009</xref>; <xref ref-type="bibr" rid="bibr10-0269881111431749">Biala et al., 2010</xref>). Thus, the results of the present study further add to the growing literature that nicotinic acetylcholine receptors are involved in the stress- and ethanol-induced activation of ethanol relapse.</p>
<p>CPP is a simple non-invasive method, compatible with classical Pavlovian conditioning (<xref ref-type="bibr" rid="bibr27-0269881111431749">Itzhak and Martin, 2002</xref>). In this paradigm, animals are initially trained to associate a distinctive environment with drug injection, and a different environment with vehicle injection. Following training, animals spend more time in the drug-paired environment, when given a choice between the two environments on a drug-free test day. This acquired preference can be abolished by daily injections of saline (alternatively, the days without any injections) with free access to both drug-paired and saline-paired environments. It was found that after extinction, the non-contingent exposure to the drug of abuse acts to renew the significance and attractiveness of the drug-related environmental stimuli (the incentive value of drug-associated cues), drawing the animal to approach and remain in the presence of the drug-related stimuli, resulting in the reinstatement of the CPP (<xref ref-type="bibr" rid="bibr45-0269881111431749">Mueller and Stewart, 2000</xref>; <xref ref-type="bibr" rid="bibr49-0269881111431749">Parker and McDonald, 2000</xref>). This animal model has been used to measure the appetitive value of different stimuli as well as to evaluate relapse to drug abuse. Thus, the results in the present study hint towards the possible use of mecamylamine in treatment of alcoholism, especially to aid patients from relapse.</p>
<p>Previous studies have reported that various stressors like intermittent unpredictable foot-shock, restraint, conditioned fear, social defeat, swim stress, and tail pinch reinstate the drug-induced CPP in rodents (for reviews see <xref ref-type="bibr" rid="bibr1-0269881111431749">Aguilar et al., 2009</xref>; <xref ref-type="bibr" rid="bibr55-0269881111431749">Shalev et al., 2010</xref>). However, herein we have shown that forced swim stress and restraint stress reinstate the ethanol-induced CPP. Further, the results also revealed that the lower dose of ethanol (lower than conditioning), which in an ethanol-naïve animal failed to induce significant place preference (data not shown), reinstate the ethanol-induced CPP, which is well in accordance with earlier reports (<xref ref-type="bibr" rid="bibr57-0269881111431749">Shoblock et al., 2011</xref>). There is a large body of experimental reports demonstrating reliable ethanol-induced CPP in inbred and outbred mice (<xref ref-type="bibr" rid="bibr20-0269881111431749">Cunningham et al., 1991</xref>; <xref ref-type="bibr" rid="bibr18-0269881111431749">Crabbe et al., 1992</xref>; <xref ref-type="bibr" rid="bibr19-0269881111431749">Cunningham, 1995</xref>; <xref ref-type="bibr" rid="bibr54-0269881111431749">Risinger and Oakes, 1996</xref>; <xref ref-type="bibr" rid="bibr4-0269881111431749">Bhutada et al., 2010a</xref>). In the present study, ethanol at a dose of 2.0 g/kg produced the maximal place conditioning effect in male albino Swiss mice (effects of other doses not shown). Reinstatement of CPP has also been demonstrated in Swiss mice with ethanol in earlier studies (<xref ref-type="bibr" rid="bibr31-0269881111431749">Kuzmin et al., 2003</xref>; <xref ref-type="bibr" rid="bibr23-0269881111431749">Font et al., 2008</xref>). In the present study, a single session of forced swim stress or restraint stress was able to reinstate ethanol-induced CPP when mice were tested 10 min after the stressor. The ability of either single or multiple sessions of forced swim stress or restraint stress are reported to induce reinstatement of cocaine- and morphine-induced CPP and drug-seeking behavior (<xref ref-type="bibr" rid="bibr44-0269881111431749">McLaughlin et al., 2003</xref>; <xref ref-type="bibr" rid="bibr43-0269881111431749">2006</xref>; <xref ref-type="bibr" rid="bibr29-0269881111431749">Kreibich and Blendy, 2004</xref>; <xref ref-type="bibr" rid="bibr53-0269881111431749">Ribeiro Do Couto et al., 2006</xref>; <xref ref-type="bibr" rid="bibr15-0269881111431749">Carey et al., 2007</xref>).</p>
<p>Stress is an important factor precipitating relapse in otherwise abstinent alcoholics (<xref ref-type="bibr" rid="bibr14-0269881111431749">Brown et al., 1995</xref>). However, the development of medications to specifically treat stress-induced relapse is problematic because many anxiety medications, such as benzodiazepines, are addictive. Moreover, the approved medicine for treatment of alcoholism involves opioidergic mechanism, and reportedly modulates the reinstatement of ethanol-induced CPP and ethanol self-administration (<xref ref-type="bibr" rid="bibr37-0269881111431749">Le et al., 1999</xref>; <xref ref-type="bibr" rid="bibr31-0269881111431749">Kuzmin et al., 2003</xref>). Interestingly, results of the present study revealed that mecamylamine blocked the ethanol-induced as well as stress-induced reinstatement of ethanol- CPP, which indicate that mecamylamine may have therapeutic potential in alcoholism.</p>
<p>A variety of neurotransmitters including dopamine have been reported to modulate ethanol self-administration, place preference, and reinstatement of place preference and self-administration. The literature suggest a critical role for dopamine acting via D1, D2, and D3 receptors in the nucleus accumbens in the reinstatement of responding for ethanol cues, and antagonist of these receptors are reported to block the ethanol reinstatement responses (<xref ref-type="bibr" rid="bibr38-0269881111431749">Liu and Weiss, 2002</xref>; <xref ref-type="bibr" rid="bibr64-0269881111431749">Vengeliene et al., 2006</xref>; <xref ref-type="bibr" rid="bibr16-0269881111431749">Chaudhri et al., 2009</xref>). Interestingly, earlier studies have shown that mecamylamine delivered systemically or directly into the ventral tegmental area blocks elevation of ethanol-mediated dopamine release in the nucleus accumbens (<xref ref-type="bibr" rid="bibr35-0269881111431749">Larsson et al., 2002</xref>, <xref ref-type="bibr" rid="bibr34-0269881111431749">2004</xref>). Recently, it is also reported that mecamylamine significantly reduces the number of DAergic neurons in the ventral tegmental area that were activated by repeated exposure to ethanol (<xref ref-type="bibr" rid="bibr26-0269881111431749">Hendrickson et al., 2009</xref>). These reports indicate the nicotinic acetylcholine receptors modulate the dopaminergic neurotransmission and thereby exert the effects on ethanol-induced CPP.</p>
<p>Furthermore, it is reported that repeated administration of ethanol results in a long-lasting increase in the activity of the NR2B-NMDARs in the brain and inhibition of glutamate neurotransmission (NR2B-NMDARs activity) significantly decreases operant self-administration of ethanol and reduces ethanol-priming-induced reinstatement of ethanol-seeking behavior and relapse (<xref ref-type="bibr" rid="bibr58-0269881111431749">Siggins et al., 2003</xref>; <xref ref-type="bibr" rid="bibr3-0269881111431749">Backstrom and Hyytia, 2004</xref>; <xref ref-type="bibr" rid="bibr2-0269881111431749">Bachteler et al., 2005</xref>; <xref ref-type="bibr" rid="bibr65-0269881111431749">Wang et al., 2010</xref>). Mecamylamine is reported to non-competitively inhibit NMDA receptors (<xref ref-type="bibr" rid="bibr48-0269881111431749">O’Dell and Christensen, 1988</xref>; <xref ref-type="bibr" rid="bibr25-0269881111431749">Fu et al., 2008</xref>). In addition, nicotinic acetylcholine receptors antagonists, including mecamylamine, block NMDA-induced behavioral effects and exhibit NMDA receptor antagonist-like effects in experimental animals (<xref ref-type="bibr" rid="bibr42-0269881111431749">McDonough and Shih, 1995</xref>). Furthermore, it is also well established that certain types of NMDA receptor antagonists (channel blockers) potently bind to nicotinic receptors and may act as nicotinic receptor antagonists (for reviews, see <xref ref-type="bibr" rid="bibr67-0269881111431749">Zakharova et al., 2005</xref>). Therefore, the modulation of NMDA and/or nACh receptors in the effects of mecamylamine during the blockade of reinstatement of ethanol-induced CPP cannot be ruled out.</p>
<p>In conclusion, mecamylamine administration prevented the development and expression of ethanol-induced place conditioning as well as the reinstatement of ethanol CPP induced by ethanol itself as well as by restraint stress or forced swim stress in ethanol-conditioned mice, which implicates cholinergic nicotinic receptors. However, in the present context, the participation of other neurotransmitter systems in this effect cannot be ruled out.</p>
</sec>
</body>
<back>
<ack>
<p>The authors are grateful to Dr Dadasaheb Kokare, Professor RTM Nagpur University for his suggestions.</p>
</ack>
<sec id="section19-0269881111431749">
<title>Funding</title>
<p>The authors would like to thank Pandit Shree Shankarprasad Agnihotri, President, and Mr Sachin Agnihotri, Chairman, Jai Mahakali Shikshan Sanstha, Wardha, for funding the research under the head of excellence in research and academics.</p>
</sec>
<sec id="section20-0269881111431749">
<title>Conflict of interest</title>
<p>All of the authors hereby declare that there is no conflict of interest.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="bibr1-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aguilar</surname><given-names>MA</given-names></name>
<name><surname>Rodríguez-Arias</surname><given-names>M</given-names></name>
<name><surname>Miñarro</surname><given-names>J</given-names></name>
</person-group> (<year>2009</year>) <article-title>Neurobiological mechanisms of the reinstatement of drug-conditioned place preference</article-title>. <source>Brain Res Rev</source> <volume>59</volume>: <fpage>253</fpage>–<lpage>277</lpage>.</citation>
</ref>
<ref id="bibr2-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bachteler</surname><given-names>D</given-names></name>
<name><surname>Economidou</surname><given-names>D</given-names></name>
<name><surname>Danysz</surname><given-names>W</given-names></name>
<name><surname>Ciccocioppo</surname><given-names>R</given-names></name>
<name><surname>Spanagel</surname><given-names>R</given-names></name>
</person-group> (<year>2005</year>) <article-title>The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat</article-title>. <source>Neuropsychopharmacology</source> <volume>30</volume>: <fpage>1104</fpage>–<lpage>1110</lpage>.</citation>
</ref>
<ref id="bibr3-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Backstrom</surname><given-names>P</given-names></name>
<name><surname>Hyytia</surname><given-names>P</given-names></name>
</person-group> (<year>2004</year>) <article-title>Ionotropic glutamate receptor antagonists modulate cue-induced reinstatement of ethanol-seeking behavior</article-title>. <source>Alcohol Clin Exp Res</source> <volume>28</volume>: <fpage>558</fpage>–<lpage>565</lpage>.</citation>
</ref>
<ref id="bibr4-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bhutada</surname><given-names>P</given-names></name>
<name><surname>Mundhada</surname><given-names>Y</given-names></name>
<name><surname>Bansod</surname><given-names>K</given-names></name>
<name><surname>Rathod</surname><given-names>S</given-names></name>
<name><surname>Hiware</surname><given-names>R</given-names></name>
<name><surname>Dixit</surname><given-names>P</given-names></name><etal/>
</person-group>. (<year>2010a</year>) <article-title>Inhibitory effect of berberine on the motivational effects of ethanol in mice</article-title>. <source>Prog Neuropsychopharmacol Biol Psychiatry</source> <volume>34</volume>: <fpage>1472</fpage>–<lpage>1479</lpage>.</citation>
</ref>
<ref id="bibr5-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bhutada</surname><given-names>P</given-names></name>
<name><surname>Mundhada</surname><given-names>Y</given-names></name>
<name><surname>Bansod</surname><given-names>K</given-names></name>
<name><surname>Ubgade</surname><given-names>A</given-names></name>
<name><surname>Quazi</surname><given-names>M</given-names></name>
<name><surname>Umathe</surname><given-names>S</given-names></name><etal/>
</person-group>. (<year>2010b</year>) <article-title>Reversal by quercetin of corticotrophin releasing factor induced anxiety- and depression-like effect in mice</article-title>. <source>Prog Neuropsychopharmacol Biol Psychiatry</source> <volume>34</volume>: <fpage>955</fpage>–<lpage>960</lpage>.</citation>
</ref>
<ref id="bibr6-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bhutada</surname><given-names>PS</given-names></name>
<name><surname>Mundhada</surname><given-names>YR</given-names></name>
<name><surname>Bansod</surname><given-names>KU</given-names></name>
<name><surname>Dixit</surname><given-names>PV</given-names></name>
<name><surname>Umathe</surname><given-names>SN</given-names></name>
<name><surname>Mundhada</surname><given-names>DR</given-names></name>
</person-group> (<year>2010c</year>) <article-title>Inhibitory influence of mecamylamine on the development and the expression of ethanol-induced locomotor sensitization in mice</article-title>. <source>Pharmacol Biochem Behav</source> <volume>96</volume>: <fpage>266</fpage>–<lpage>273</lpage>.</citation>
</ref>
<ref id="bibr7-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bhutada</surname><given-names>PS</given-names></name>
<name><surname>Mundhada</surname><given-names>YR</given-names></name>
<name><surname>Bansod</surname><given-names>KU</given-names></name>
<name><surname>Umathe</surname><given-names>SN</given-names></name>
<name><surname>Kahale</surname><given-names>VP</given-names></name>
<name><surname>Dixit</surname><given-names>PV</given-names></name><etal/>
</person-group>. (<year>2010d</year>) <article-title>Inhibitory influence of mecamylamine on ethanol withdrawal-induced symptoms in C57BL/6J mice</article-title>. <source>Behav Pharmacol</source> <volume>21</volume>: <fpage>90</fpage>–<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr8-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Biala</surname><given-names>G</given-names></name>
<name><surname>Budzynska</surname><given-names>B</given-names></name>
</person-group> (<year>2006</year>) <article-title>Reinstatement of nicotine-conditioned place preference by drug priming: effects of calcium channel antagonists</article-title>. <source>Eur J Pharmacol</source> <volume>537</volume>: <fpage>85</fpage>–<lpage>93</lpage>.</citation>
</ref>
<ref id="bibr9-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Biala</surname><given-names>G</given-names></name>
<name><surname>Budzynska</surname><given-names>B</given-names></name>
</person-group> (<year>2008</year>) <article-title>Calcium-dependent mechanisms of the reinstatement of nicotine-conditioned place preference by drug priming in rats</article-title>. <source>Pharmacol Biochem Behav</source> <volume>89</volume>: <fpage>116</fpage>–<lpage>125</lpage>.</citation>
</ref>
<ref id="bibr10-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Biala</surname><given-names>G</given-names></name>
<name><surname>Staniak</surname><given-names>N</given-names></name>
<name><surname>Budzynska</surname><given-names>B</given-names></name>
</person-group> (<year>2010</year>) <article-title>Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats</article-title>. <source>Naunyn Schmiedebergs Arch Pharmacol</source> <volume>381</volume>: <fpage>361</fpage>–<lpage>370</lpage>.</citation>
</ref>
<ref id="bibr11-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Blomqvist</surname><given-names>O</given-names></name>
<name><surname>Ericson</surname><given-names>M</given-names></name>
<name><surname>Johnson</surname><given-names>DH</given-names></name>
<name><surname>Engel</surname><given-names>JA</given-names></name>
<name><surname>Söderpalm</surname><given-names>B</given-names></name>
</person-group> (<year>1996</year>) <article-title>Voluntary ethanol intake in the rat: effects of nicotinic acetylcholine receptor blockade or subchronic nicotine treatment</article-title>. <source>Eur J Pharmacol</source> <volume>314</volume>: <fpage>257</fpage>–<lpage>267</lpage>.</citation>
</ref>
<ref id="bibr12-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Blomqvist</surname><given-names>O</given-names></name>
<name><surname>Hernandez-Avila</surname><given-names>CA</given-names></name>
<name><surname>Van Kirk</surname><given-names>J</given-names></name>
<name><surname>Rose</surname><given-names>JE</given-names></name>
<name><surname>Kranzler</surname><given-names>HR</given-names></name>
</person-group> (<year>2002</year>) <article-title>Mecamylamine modifies the pharmacokinetics and reinforcing effects of alcohol</article-title>. <source>Alcohol Clin Exp Res</source> <volume>26</volume>: <fpage>326</fpage>–<lpage>331</lpage>.</citation>
</ref>
<ref id="bibr13-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brady</surname><given-names>KT</given-names></name>
<name><surname>Sonne</surname><given-names>SC</given-names></name>
</person-group> (<year>1999</year>) <article-title>The role of stress in alcohol use, alcoholism treatment, and relapse</article-title>. <source>Alcohol Res Health</source> <volume>23</volume>: <fpage>263</fpage>–<lpage>271</lpage>.</citation>
</ref>
<ref id="bibr14-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brown</surname><given-names>SA</given-names></name>
<name><surname>Vik</surname><given-names>PW</given-names></name>
<name><surname>Patterson</surname><given-names>TL</given-names></name>
<name><surname>Grant</surname><given-names>I</given-names></name>
<name><surname>Schuckit</surname><given-names>MA</given-names></name>
</person-group> (<year>1995</year>) <article-title>Stress, vulnerability and adult alcohol relapse</article-title>. <source>J Stud Alcohol</source> <volume>56</volume>: <fpage>538</fpage>–<lpage>545</lpage>.</citation>
</ref>
<ref id="bibr15-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carey</surname><given-names>AN</given-names></name>
<name><surname>Borozny</surname><given-names>K</given-names></name>
<name><surname>Aldrich</surname><given-names>JV</given-names></name>
<name><surname>McLaughlin</surname><given-names>JP</given-names></name>
</person-group> (<year>2007</year>) <article-title>Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn</article-title>. <source>Eur J Pharmacol</source> <volume>569</volume>: <fpage>84</fpage>–<lpage>89</lpage>.</citation>
</ref>
<ref id="bibr16-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chaudhri</surname><given-names>N</given-names></name>
<name><surname>Sahuque</surname><given-names>LL</given-names></name>
<name><surname>Janak</surname><given-names>PH</given-names></name>
</person-group> (<year>2009</year>) <article-title>Ethanol seeking triggered by environmental context is attenuated by blocking dopamine D1 receptors in the nucleus accumbens core and shell in rats</article-title>. <source>Psychopharmacology</source> <volume>207</volume>: <fpage>303</fpage>–<lpage>314</lpage>.</citation>
</ref>
<ref id="bibr17-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chi</surname><given-names>H</given-names></name>
<name><surname>de Wit</surname><given-names>H</given-names></name>
</person-group> (<year>2003</year>) <article-title>Mecamylamine attenuates the subjective stimulant-like effects of alcohol in social drinkers</article-title>. <source>Alcohol Clin Exp Res</source> <volume>27</volume>: <fpage>780</fpage>–<lpage>786</lpage>.</citation>
</ref>
<ref id="bibr18-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Crabbe</surname><given-names>JC</given-names></name>
<name><surname>Phillips</surname><given-names>TJ</given-names></name>
<name><surname>Cunningham</surname><given-names>CL</given-names></name>
<name><surname>Belknap</surname><given-names>JK</given-names></name>
</person-group> (<year>1992</year>) <article-title>Genetic determinants of ethanol reinforcement</article-title>. <source>Ann N Y Acad Sci</source> <volume>654</volume>: <fpage>302</fpage>–<lpage>310</lpage>.</citation>
</ref>
<ref id="bibr19-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cunningham</surname><given-names>CL</given-names></name>
</person-group> (<year>1995</year>) <article-title>Localization of genes influencing ethanol-induced conditioned place preference and locomotor activity in BXD recombinant inbred mice</article-title>. <source>Psychopharmacology (Berl)</source> <volume>120</volume>: <fpage>28</fpage>–<lpage>41</lpage>.</citation>
</ref>
<ref id="bibr20-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cunningham</surname><given-names>CL</given-names></name>
<name><surname>Hallett</surname><given-names>CL</given-names></name>
<name><surname>Niehus</surname><given-names>DR</given-names></name>
<name><surname>Hunter</surname><given-names>JS</given-names></name>
<name><surname>Nouth</surname><given-names>L</given-names></name>
<name><surname>Risinger</surname><given-names>FO</given-names></name>
</person-group> (<year>1991</year>) <article-title>Assessment of ethanol’s hedonic effects in mice selectively bred for sensitivity to ethanol-induced hypothermia</article-title>. <source>Psychopharmacology (Berl)</source> <volume>105</volume>: <fpage>84</fpage>–<lpage>92</lpage>.</citation>
</ref>
<ref id="bibr21-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fiore</surname><given-names>MC</given-names></name>
</person-group> (<year>2000</year>) <article-title>US public health service clinical practice guideline: treating tobacco use and dependence</article-title>. <source>Respir Care</source> <volume>45</volume>: <fpage>1200</fpage>–<lpage>1062</lpage>.</citation>
</ref>
<ref id="bibr22-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Font</surname><given-names>L</given-names></name>
<name><surname>Aragon</surname><given-names>CM</given-names></name>
<name><surname>Miquel</surname><given-names>M</given-names></name>
</person-group> (<year>2006</year>) <article-title>Ethanol-induced conditioned place preference, but not aversion, is blocked by treatment with D-penicillamine, an inactivation agent for acetaldehyde</article-title>. <source>Psychopharmacology (Berl)</source> <volume>184</volume>: <fpage>56</fpage>–<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr23-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Font</surname><given-names>L</given-names></name>
<name><surname>Miquel</surname><given-names>M</given-names></name>
<name><surname>Aragon</surname><given-names>CM</given-names></name>
</person-group> (<year>2008</year>) <article-title>Involvement of brain catalase activity in the acquisition of ethanol-induced conditioned place preference</article-title>. <source>Physiol Behav</source> <volume>93</volume>: <fpage>733</fpage>–<lpage>741</lpage>.</citation>
</ref>
<ref id="bibr24-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ford</surname><given-names>MM</given-names></name>
<name><surname>Fretwell</surname><given-names>AM</given-names></name>
<name><surname>Nickel</surname><given-names>JD</given-names></name>
<name><surname>Mark</surname><given-names>GP</given-names></name>
<name><surname>Strong</surname><given-names>MN</given-names></name>
<name><surname>Yoneyama</surname><given-names>N</given-names></name><etal/>
</person-group>. (<year>2009</year>) <article-title>The influence of mecamylamine on ethanol and sucrose self-administration</article-title>. <source>Neuropharmacology</source> <volume>57</volume>: <fpage>250</fpage>–<lpage>258</lpage>.</citation>
</ref>
<ref id="bibr25-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fu</surname><given-names>H</given-names></name>
<name><surname>Dou</surname><given-names>J</given-names></name>
<name><surname>Li</surname><given-names>W</given-names></name>
<name><surname>Luo</surname><given-names>J</given-names></name>
<name><surname>Li</surname><given-names>KC</given-names></name>
<name><surname>Lam</surname><given-names>CS</given-names></name>
</person-group> (<year>2008</year>) <article-title>Mecamylamine prevents neuronal apoptosis induced by glutamate and low potassium via differential anticholinergic independent mechanisms</article-title>. <source>Neuropharmacology</source> <volume>54</volume>: <fpage>755</fpage>–<lpage>765</lpage>.</citation>
</ref>
<ref id="bibr26-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hendrickson</surname><given-names>LM</given-names></name>
<name><surname>Zhao-Shea</surname><given-names>R</given-names></name>
<name><surname>Tapper</surname><given-names>AR</given-names></name>
</person-group> (<year>2009</year>) <article-title>Modulation of ethanol drinking-in-the-dark by mecamylamine and nicotinic acetylcholine receptor agonists in C57BL/6J mice</article-title>. <source>Psychopharmacology (Berl)</source> <volume>204</volume>: <fpage>563</fpage>–<lpage>572</lpage>.</citation>
</ref>
<ref id="bibr27-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Itzhak</surname><given-names>Y</given-names></name>
<name><surname>Martin</surname><given-names>JL</given-names></name>
</person-group> (<year>2002</year>) <article-title>Cocaine-induced conditioned place preference in mice: induction, extinction and reinstatement by related psychostimulants</article-title>. <source>Neuropsychopharmacology</source> <volume>26</volume>: <fpage>130</fpage>–<lpage>134</lpage>.</citation>
</ref>
<ref id="bibr28-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kamens</surname><given-names>HM</given-names></name>
<name><surname>Andersen</surname><given-names>J</given-names></name>
<name><surname>Picciotto</surname><given-names>MR</given-names></name>
</person-group> (<year>2010</year>) <article-title>Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice</article-title>. <source>Psychopharmacology (Berl)</source> <volume>208</volume>: <fpage>613</fpage>–<lpage>626</lpage>.</citation>
</ref>
<ref id="bibr29-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kreibich</surname><given-names>AS</given-names></name>
<name><surname>Blendy</surname><given-names>JA</given-names></name>
</person-group> (<year>2004</year>) <article-title>cAMP response element-binding protein is required for stress but not cocaine-induced reinstatement</article-title>. <source>J Neurosci</source> <volume>24</volume>: <fpage>6686</fpage>–<lpage>6692</lpage>.</citation>
</ref>
<ref id="bibr30-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kuzmin</surname><given-names>A</given-names></name>
<name><surname>Jerlhag</surname><given-names>E</given-names></name>
<name><surname>Liljequist</surname><given-names>S</given-names></name>
<name><surname>Engel</surname><given-names>J</given-names></name>
</person-group> (<year>2009</year>) <article-title>Effects of subunit selective nACh receptors on operant ethanol self-administration and relapse-like ethanol-drinking behavior</article-title>. <source>Psychopharmacology (Berl)</source> <volume>203</volume>: <fpage>99</fpage>–<lpage>108</lpage>.</citation>
</ref>
<ref id="bibr31-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kuzmin</surname><given-names>A</given-names></name>
<name><surname>Sandin</surname><given-names>J</given-names></name>
<name><surname>Terenius</surname><given-names>L</given-names></name>
<name><surname>Ogren</surname><given-names>SO</given-names></name>
</person-group> (<year>2003</year>) <article-title>Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of opioid receptor-like 1 receptor agonists and naloxone</article-title>. <source>JPET</source> <volume>304</volume>: <fpage>310</fpage>–<lpage>318</lpage>.</citation>
</ref>
<ref id="bibr32-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lamon</surname><given-names>BC</given-names></name>
<name><surname>Alonzo</surname><given-names>A</given-names></name>
</person-group> (<year>1997</year>) <article-title>Stress among males recovering from substance abuse</article-title>. <source>Addict Behav</source> <volume>22</volume>: <fpage>195</fpage>–<lpage>205</lpage>.</citation>
</ref>
<ref id="bibr33-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Larsson</surname><given-names>A</given-names></name>
<name><surname>Engel</surname><given-names>JA</given-names></name>
</person-group> (<year>2004</year>) <article-title>Neurochemical and behavioral studies on ethanol and nicotine interactions</article-title>. <source>Neurosci Biobehav Rev</source> <volume>27</volume>: <fpage>713</fpage>–<lpage>720</lpage>.</citation>
</ref>
<ref id="bibr34-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Larsson</surname><given-names>A</given-names></name>
<name><surname>Jerlhag</surname><given-names>E</given-names></name>
<name><surname>Svensson</surname><given-names>L</given-names></name>
<name><surname>Soderpalm</surname><given-names>B</given-names></name>
<name><surname>Engel</surname><given-names>JA</given-names></name>
</person-group> (<year>2004</year>) <article-title>Is an α-conotoxin MII–sensitive mechanism involved in the neurochemical, stimulatory, and rewarding effects of ethanol?</article-title> <source>Alcohol</source> <volume>34</volume>: <fpage>239</fpage>–<lpage>250</lpage>.</citation>
</ref>
<ref id="bibr35-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Larsson</surname><given-names>A</given-names></name>
<name><surname>Svensson</surname><given-names>L</given-names></name>
<name><surname>Soderpalm</surname><given-names>B</given-names></name>
<name><surname>Engel</surname><given-names>JA</given-names></name>
</person-group> (<year>2002</year>) <article-title>Role of different nicotinic acetylcholine receptors in mediating behavioral and neurochemical effects of ethanol in mice</article-title>. <source>Alcohol</source> <volume>28</volume>: <fpage>157</fpage>–<lpage>167</lpage>.</citation>
</ref>
<ref id="bibr36-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Le</surname><given-names>AD</given-names></name>
<name><surname>Corrigall</surname><given-names>WA</given-names></name>
<name><surname>Harding</surname><given-names>JW</given-names></name>
<name><surname>Juzytsch</surname><given-names>W</given-names></name>
<name><surname>Li</surname><given-names>TK</given-names></name>
</person-group> (<year>2000</year>) <article-title>Involvement of nicotinic receptors in alcohol self-administration</article-title>. <source>Alcohol Clin Exp Res</source> <volume>24</volume>: <fpage>155</fpage>–<lpage>163</lpage>.</citation>
</ref>
<ref id="bibr37-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Le</surname><given-names>AD</given-names></name>
<name><surname>Poulos</surname><given-names>CX</given-names></name>
<name><surname>Harding</surname><given-names>S</given-names></name>
<name><surname>Watchus</surname><given-names>J</given-names></name>
<name><surname>Juzytsch</surname><given-names>W</given-names></name>
<name><surname>Shaham</surname><given-names>Y</given-names></name>
</person-group> (<year>1999</year>) <article-title>Effects of naltrexone and fluoxetine on alcohol self- administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress</article-title>. <source>Neuropsychopharmacology</source> <volume>21</volume>: <fpage>435</fpage>–<lpage>44</lpage>.</citation>
</ref>
<ref id="bibr38-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname><given-names>X</given-names></name>
<name><surname>Weiss</surname><given-names>F</given-names></name>
</person-group> (<year>2002</year>) <article-title>Reversal of ethanol-seeking behavior by D1 and D2 antagonists in an animal model of relapse: differences in antagonist potency in previously ethanol-dependent versus nondependent rats</article-title>. <source>JPET</source> <volume>300</volume>: <fpage>882</fpage>–<lpage>889</lpage>.</citation>
</ref>
<ref id="bibr39-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lof</surname><given-names>E</given-names></name>
<name><surname>Olausson</surname><given-names>P</given-names></name>
<name><surname>deBejczy</surname><given-names>A</given-names></name>
<name><surname>Stomberg</surname><given-names>R</given-names></name>
<name><surname>McIntosh</surname><given-names>JM</given-names></name>
<name><surname>Taylor</surname><given-names>JR</given-names></name><etal/>
</person-group>. (<year>2007</year>) <article-title>Nicotinic acetylcholine receptors in the ventral tegmental area mediate the dopamine activating and reinforcing properties of ethanol cues</article-title>. <source>Psychopharmacology (Berl)</source> <volume>195</volume>: <fpage>333</fpage>–<lpage>343</lpage>.</citation>
</ref>
<ref id="bibr40-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lu</surname><given-names>L</given-names></name>
<name><surname>Chen</surname><given-names>H</given-names></name>
<name><surname>Su</surname><given-names>W</given-names></name>
<name><surname>Ge</surname><given-names>X</given-names></name>
<name><surname>Yue</surname><given-names>W</given-names></name>
<name><surname>Su</surname><given-names>F</given-names></name><etal/>
</person-group>. (<year>2005</year>) <article-title>Role of withdrawal in reinstatement of morphine-conditioned place preference</article-title>. <source>Psychopharmacology (Berl)</source> <volume>181</volume>: <fpage>90</fpage>–<lpage>100</lpage>.</citation>
</ref>
<ref id="bibr41-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Maurice</surname><given-names>T</given-names></name>
<name><surname>Casalino</surname><given-names>M</given-names></name>
<name><surname>Lacroix</surname><given-names>M</given-names></name>
<name><surname>Romieu</surname><given-names>P</given-names></name>
</person-group> (<year>2003</year>) <article-title>Involvement of the sigma 1 receptor in the motivational effects of ethanol in mice</article-title>. <source>Pharmacol Biochem Behav</source> <volume>74</volume>: <fpage>869</fpage>–<lpage>876</lpage>.</citation>
</ref>
<ref id="bibr42-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McDonough</surname><given-names>JH</given-names><suffix>Jr</suffix></name>
<name><surname>Shih</surname><given-names>TM</given-names></name>
</person-group> (<year>1995</year>) <article-title>A study of the N-methyl-D-aspartate antagonistic properties of anticholinergic drugs</article-title>. <source>Pharmacol Biochem Behav</source> <volume>51</volume>: <fpage>249</fpage>–<lpage>253</lpage>.</citation>
</ref>
<ref id="bibr43-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McLaughlin</surname><given-names>JP</given-names></name>
<name><surname>Land</surname><given-names>BB</given-names></name>
<name><surname>Li</surname><given-names>S</given-names></name>
<name><surname>Pintar</surname><given-names>JE</given-names></name>
<name><surname>Chavkin</surname><given-names>C</given-names></name>
</person-group> (<year>2006</year>) <article-title>Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning</article-title>. <source>Neuropsychopharmacology</source> <volume>31</volume>: <fpage>787</fpage>–<lpage>794</lpage>.</citation>
</ref>
<ref id="bibr44-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McLaughlin</surname><given-names>JP</given-names></name>
<name><surname>Marton-Popovici</surname><given-names>M</given-names></name>
<name><surname>Chavkin</surname><given-names>C</given-names></name>
</person-group> (<year>2003</year>) <article-title>Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses</article-title>. <source>J Neurosci</source> <volume>23</volume>: <fpage>5674</fpage>–<lpage>5683</lpage>.</citation>
</ref>
<ref id="bibr45-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mueller</surname><given-names>D</given-names></name>
<name><surname>Stewart</surname><given-names>J</given-names></name>
</person-group> (<year>2000</year>) <article-title>Cocaine-induced conditioned place preference: reinstatement by priming injections of cocaine after extinction</article-title>. <source>Behav Brain Res</source> <volume>115</volume>: <fpage>39</fpage>–<lpage>47</lpage>.</citation>
</ref>
<ref id="bibr46-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nadal</surname><given-names>R</given-names></name>
<name><surname>Chappell</surname><given-names>AM</given-names></name>
<name><surname>Samson</surname><given-names>HH</given-names></name>
</person-group> (<year>1998</year>) <article-title>Effects of nicotine and mecamylamine microinjections into the nucleus accumbens on ethanol and sucrose self-administration</article-title>. <source>Alcohol Clin Exp Res</source> <volume>22</volume>: <fpage>1190</fpage>–<lpage>1198</lpage>.</citation>
</ref>
<ref id="bibr47-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nestler</surname><given-names>EJ</given-names></name>
</person-group> (<year>2004</year>) <article-title>Molecular mechanisms of drug addiction</article-title>. <source>Neuropharmacology</source> <volume>47</volume>: <fpage>24</fpage>–<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr48-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>O’Dell</surname><given-names>TJ</given-names></name>
<name><surname>Christensen</surname><given-names>BN</given-names></name>
</person-group> (<year>1988</year>) <article-title>Mecamylamine is a selective non-competitive antagonist of N-methyl-D-aspartate- and aspartate-induced currents in horizontal cells dissociated from the catfish retina</article-title>. <source>Neurosci Lett</source> <volume>94</volume>: <fpage>93</fpage>–<lpage>98</lpage>.</citation>
</ref>
<ref id="bibr49-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Parker</surname><given-names>LA</given-names></name>
<name><surname>McDonald</surname><given-names>RV</given-names></name>
</person-group> (<year>2000</year>) <article-title>Reinstatement of both a conditioned place preference and a conditioned place aversion with drug primes</article-title>. <source>Pharmacol Biochem Behav</source> <volume>66</volume>: <fpage>559</fpage>–<lpage>561</lpage>.</citation>
</ref>
<ref id="bibr50-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pascual</surname><given-names>MM</given-names></name>
<name><surname>Pastor</surname><given-names>V</given-names></name>
<name><surname>Bernabeu</surname><given-names>RO</given-names></name>
</person-group> (<year>2009</year>) <article-title>Nicotine-conditioned place preference induced CREB phosphorylation and Fos expression in the adult rat brain</article-title>. <source>Psychopharmacology (Berl)</source> <volume>207</volume>: <fpage>57</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr51-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pohorecky</surname><given-names>LA</given-names></name>
</person-group> (<year>1981</year>) <article-title>The interaction of alcohol and stress. A review</article-title>. <source>Neurosci Biobehav</source> <volume>5</volume>: <fpage>209</fpage>–<lpage>229</lpage>.</citation>
</ref>
<ref id="bibr52-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rezayof</surname><given-names>A</given-names></name>
<name><surname>Nazari-Serenjeh</surname><given-names>F</given-names></name>
<name><surname>Zarrindast</surname><given-names>MR</given-names></name>
<name><surname>Sepehri</surname><given-names>H</given-names></name>
<name><surname>Delphi</surname><given-names>L</given-names></name>
</person-group> (<year>2007</year>) <article-title>Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area</article-title>. <source>Eur J Pharmacol</source> <volume>562</volume>: <fpage>92</fpage>–<lpage>102</lpage>.</citation>
</ref>
<ref id="bibr53-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ribeiro</surname><given-names>Do</given-names></name>
<name><surname>Couto</surname><given-names>B</given-names></name>
<name><surname>Aguilar</surname><given-names>MA</given-names></name>
<name><surname>Manzanedo</surname><given-names>C</given-names></name>
<name><surname>Rodríguez-Arias</surname><given-names>M</given-names></name>
<name><surname>Armario</surname><given-names>A</given-names></name>
<name><surname>Miñarro</surname><given-names>J</given-names></name>
</person-group> (<year>2006</year>) <article-title>Social stress is as effective as physical stress in reinstating morphine-induced place preference in mice</article-title>. <source>Psychopharmacology (Berl)</source> <volume>185</volume>: <fpage>459</fpage>–<lpage>470</lpage>.</citation>
</ref>
<ref id="bibr54-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Risinger</surname><given-names>FO</given-names></name>
<name><surname>Oakes</surname><given-names>RA</given-names></name>
</person-group> (<year>1996</year>) <article-title>Dose- and conditioning trial-dependent ethanol-induced conditioned place preference in Swiss–Webster mice</article-title>. <source>Pharmacol Biochem Behav</source> <volume>55</volume>: <fpage>117</fpage>–<lpage>123</lpage>.</citation>
</ref>
<ref id="bibr55-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shalev</surname><given-names>U</given-names></name>
<name><surname>Erb</surname><given-names>S</given-names></name>
<name><surname>Shaham</surname><given-names>Y</given-names></name>
</person-group> (<year>2010</year>) <article-title>Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking</article-title>. <source>Brain Res</source> <volume>1314</volume>: <fpage>15</fpage>–<lpage>28</lpage>.</citation>
</ref>
<ref id="bibr56-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shalev</surname><given-names>U</given-names></name>
<name><surname>Grimm</surname><given-names>JW</given-names></name>
<name><surname>Shaham</surname><given-names>Y</given-names></name>
</person-group> (<year>2002</year>) <article-title>Neurobiology of relapse to heroin and cocaine seeking: a review</article-title>. <source>Pharmacol Rev</source> <volume>54</volume>: <fpage>1</fpage>–<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr57-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shoblock</surname><given-names>JR</given-names></name>
<name><surname>Welty</surname><given-names>N</given-names></name>
<name><surname>Aluisio</surname><given-names>L</given-names></name>
<name><surname>Fraser</surname><given-names>I</given-names></name>
<name><surname>Motley</surname><given-names>ST</given-names></name>
<name><surname>Morton</surname><given-names>K</given-names></name><etal/>
</person-group>. (<year>2011</year>) <article-title>Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement</article-title>. <source>Psychopharmacology (Berl)</source> <volume>215</volume>: <fpage>191</fpage>–<lpage>203</lpage>.</citation>
</ref>
<ref id="bibr58-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Siggins</surname><given-names>GR</given-names></name>
<name><surname>Martin</surname><given-names>G</given-names></name>
<name><surname>Roberto</surname><given-names>M</given-names></name>
<name><surname>Nie</surname><given-names>Z</given-names></name>
<name><surname>Madamba</surname><given-names>S</given-names></name>
<name><surname>De Lecea</surname><given-names>L</given-names></name>
</person-group> (<year>2003</year>) <article-title>Glutamatergic transmission in opiate and alcohol dependence</article-title>. <source>Ann N Y Acad Sci</source> <volume>1003</volume>: <fpage>196</fpage>–<lpage>211</lpage>.</citation>
</ref>
<ref id="bibr59-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sinha</surname><given-names>R</given-names></name>
</person-group> (<year>2001</year>) <article-title>How does stress increase risk of drug abuse and relapse?</article-title> <source>Psychopharmacology (Berl)</source> <volume>158</volume>: <fpage>343</fpage>–<lpage>359</lpage>.</citation>
</ref>
<ref id="bibr60-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sinha</surname><given-names>R</given-names></name>
<name><surname>Catapano</surname><given-names>D</given-names></name>
<name><surname>O’Malley</surname><given-names>S</given-names></name>
</person-group> (<year>1999</year>) <article-title>Stress-induced craving and stress response in cocaine dependent individuals</article-title>. <source>Psychopharmacology (Berl)</source> <volume>142</volume>: <fpage>343</fpage>–<lpage>351</lpage>.</citation>
</ref>
<ref id="bibr61-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Soderpalm</surname><given-names>B</given-names></name>
<name><surname>Ericson</surname><given-names>M</given-names></name>
<name><surname>Olausson</surname><given-names>P</given-names></name>
<name><surname>Blomqvist</surname><given-names>O</given-names></name>
<name><surname>Engel</surname><given-names>JA</given-names></name>
</person-group> (<year>2000</year>) <article-title>Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol</article-title>. <source>Behav Brain Res</source> <volume>113</volume>: <fpage>85</fpage>–<lpage>96</lpage>.</citation>
</ref>
<ref id="bibr62-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sperling</surname><given-names>RE</given-names></name>
<name><surname>Gomes</surname><given-names>SM</given-names></name>
<name><surname>Sypek</surname><given-names>EI</given-names></name>
<name><surname>Carey</surname><given-names>AN</given-names></name>
<name><surname>McLaughlin</surname><given-names>JP</given-names></name>
</person-group> (<year>2010</year>) <article-title>Endogenous kappa-opioid mediation of stress-induced potentiation of ethanol-conditioned place preference and self-administration</article-title>. <source>Psychopharmacology (Berl)</source> <volume>210</volume>: <fpage>199</fpage>–<lpage>209</lpage>.</citation>
</ref>
<ref id="bibr63-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Umathe</surname><given-names>SN</given-names></name>
<name><surname>Dixit</surname><given-names>PV</given-names></name>
<name><surname>Wanjari</surname><given-names>MM</given-names></name>
<name><surname>Ullewar</surname><given-names>MP</given-names></name>
</person-group> (<year>2008</year>) <article-title>Leuprolide-a GnRH agonist prevents stress-induced immunosuppression via sex steroid-independent peripheral mechanism in mice</article-title>. <source>Int Immunopharmacol</source> <volume>8</volume>: <fpage>71</fpage>–<lpage>79</lpage>.</citation>
</ref>
<ref id="bibr64-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vengeliene</surname><given-names>V</given-names></name>
<name><surname>Leonardi-Essmann</surname><given-names>F</given-names></name>
<name><surname>Perreau-Lenz</surname><given-names>S</given-names></name>
<name><surname>Gebicke-Haerter</surname><given-names>P</given-names></name>
<name><surname>Drescher</surname><given-names>K</given-names></name>
<name><surname>Gross</surname><given-names>G</given-names></name><etal/>
</person-group>. (<year>2006</year>) <article-title>The dopamine D3 receptor plays an essential role in alcohol-seeking and relapse</article-title>. <source>FASEB J</source> <volume>20</volume>: <fpage>2223</fpage>–<lpage>2233</lpage>.</citation>
</ref>
<ref id="bibr65-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>J</given-names></name>
<name><surname>Lanfranco</surname><given-names>MF</given-names></name>
<name><surname>Gibb</surname><given-names>SL</given-names></name>
<name><surname>Yowell</surname><given-names>QV</given-names></name>
<name><surname>Carnicella</surname><given-names>S</given-names></name>
<name><surname>Ron</surname><given-names>D</given-names></name>
</person-group> (<year>2010</year>) <article-title>Long-lasting adaptations of the NR2B-containing NMDA receptors in the dorsomedial striatum play a crucial role in alcohol consumption and relapse</article-title>. <source>J Neurosci</source> <volume>30</volume>: <fpage>10187</fpage>–<lpage>10198</lpage>.</citation>
</ref>
<ref id="bibr66-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Young</surname><given-names>EM</given-names></name>
<name><surname>Mahler</surname><given-names>S</given-names></name>
<name><surname>Chi</surname><given-names>H</given-names></name>
<name><surname>de Wit</surname><given-names>H</given-names></name>
</person-group> (<year>2005</year>) <article-title>Mecamylamine and ethanol preference in healthy volunteers</article-title>. <source>Alcohol Clin Exp Res</source> <volume>29</volume>: <fpage>58</fpage>–<lpage>65</lpage>.</citation>
</ref>
<ref id="bibr67-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zakharova</surname><given-names>ES</given-names></name>
<name><surname>Danysz</surname><given-names>W</given-names></name>
<name><surname>Bespalov</surname><given-names>AY</given-names></name>
</person-group> (<year>2005</year>) <article-title>Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats</article-title>. <source>Psychopharmacology (Berl)</source> <volume>179</volume>: <fpage>128</fpage>–<lpage>135</lpage>.</citation>
</ref>
<ref id="bibr68-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zarrindast</surname><given-names>MR</given-names></name>
<name><surname>Barghi-Lashkari</surname><given-names>S</given-names></name>
<name><surname>Shafizadeh</surname><given-names>M</given-names></name>
</person-group> (<year>2001</year>) <article-title>The possible cross-tolerance between morphine- and nicotine-induced hypothermia in mice</article-title>. <source>Pharmacol Biochem Behav</source> <volume>68</volume>: <fpage>283</fpage>–<lpage>289</lpage>.</citation>
</ref>
<ref id="bibr69-0269881111431749">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zarrindast</surname><given-names>MR</given-names></name>
<name><surname>Meshkani</surname><given-names>J</given-names></name>
<name><surname>Rezayof</surname><given-names>A</given-names></name>
<name><surname>Beigzadeh</surname><given-names>R</given-names></name>
<name><surname>Rostami</surname><given-names>P</given-names></name>
</person-group> (<year>2010</year>) <article-title>Nicotinic acetylcholine receptors of the dorsal hippocampus and the basolateral amygdala are involved in ethanol-induced conditioned place preference</article-title>. <source>Neuroscience</source> <volume>168</volume>: <fpage>505</fpage>–<lpage>513</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>